> Home > Press > Press Releases > Health > 2009
Memantine enhances communication abilities in patients with Alzheimer´s disease - for a longer integration in social and family life (13 Jul 2009)
Merz Pharmaceuticals announces results of two clinical trials with NT-201 (botulinum neurotoxin type a free from complexing proteins) (06 May 2009)
Last update: 15 Jul 2009, 03:13
produced by GPM mbH
new user
URL: http://www.merz.com/press/press-releases/health/2009 Last update: 15.07.2009, 15:13 Uhr © 2010 Merz. All rights reserved.